Navigation Links
Abacus International Expands Annual Partnership With HealthEconomics.Com
Date:3/8/2013

Ponte Vedra Beach, Florida (PRWEB) March 08, 2013

HealthEconomics.Com is pleased to announce their continuing partnership with Abacus International, specialists in health economics, systematic review, and HTA.

"We're excited that Abacus has chosen not only to come aboard for a fourth year, but to expand their access to the variety of services we offer by upgrading their membership in our Annual Marketing Partnership Program,” said Dr. Patti Peeples, President of HealthEconomics.Com. “Abacus International is regarded throughout the pharmaceutical and biotech industry for their strategic consulting in health economic and evidence-based solutions for all phases of the product life cycle. Their post-launch communication tools for presenting cost and outcomes data for various customer groups is particularly well-regarded. It's an honor to know a key provider such as Abacus views HealthEconomics.Com as an important resource in promoting their ever-evolving range of services."

The HealthEconomics.Com Annual Marketing Partnership Program allows partners to communicate with a global community of 20,000 pharmaceutical, health outcomes research, pricing and reimbursement professionals by offering a tested array of digital marketing solutions. To date, 26 Annual Marketing Partners have signed with HealthEconomics.Com with >90%, like Abacus International, renewing their partnerships every year.

Founded in 1995, Abacus International (http://www.abacusint.com) develops evidence-based market access solutions for many of the world's leading healthcare companies. Key services such as strategic payer landscaping, health economics and modeling, and value communication tools provide integrated market access solutions throughout the product life-cycle of a pharmaceutical or medical device. With a reputation built on a commitment to academic rigor and keen market insight, Abacus International continues to exceed client expectations with intelligent solutions that insure the product development process, from pre-launch to market access, achieves the best possible outcome.

In December 2012 Abacus International was acquired by Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis.

HealthEconomics.Com (http://www.healtheconomics.com) is the world’s most comprehensive and credible website for resources in healthcare value and market access and is a trusted resource for the biopharmaceutical and healthcare industry. HealthEconomics.Com, established in 1994, also provides policy updates, professional development, education resources, jobs and conferences for health economics, outcomes research, and reimbursement professionals. The website attracts over 10,000 visitors every month and the well-respected HealthEconomics.Com Newsletter reaches 20,000 professionals every week.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/Abacus/prweb10425123.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Manchester leads new international study investigating Inflammatory Bowl Disease
2. Pediatric cancer charities partner to fund international collaborative research
3. Supply Chain Solutions + Business Intelligence = International Expansion for Scott Sheldon
4. Aerovox Announces Appointment of Marco Castillo to International Sales Manager
5. Global Food Protection Institute Attends International Conference on Food Safety
6. International Conference on Governance of Tobacco in the 21st Century
7. Columbus Center for Women’s Health Research is participating in an International Study for a New “Use-as-Needed” Treatment for Women with Sexual Dysfunction
8. International space station plays host to innovative infectious disease research
9. Joan W. Miller, M.D., F.A.R.V.O., elected to Academia Ophthalmologica Internationalis
10. International study suggests improved treatment alternative for lymphoid leukemia
11. 15th International Celiac Disease Symposium will unveil new research, dispel gluten-free myths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: